BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Puma Biotechnology Added to NASDAQ Biotechnology Index

  Puma will be added to the NBI effective prior to market open on Monday, December 18, 2017.

  December 14, 2017

   · 

  3 min read
• 

  Management Shakeup at Cash-Strapped Presbia, New Leader Named

  The company also received an investment proposal from Orchard Capital Corporation to invest up to $5 million in the Company’s preferred shares.

  December 14, 2017

   · 

  4 min read
• Biotech Beach

  San Diego’s AmpliPhi Biosciences Is Reviewing Strategic Alternatives

  AmpliPhi Biosciences announced its progress in 2017 and near-term strategic goals and initiatives.

  December 14, 2017

   · 

  7 min read
• Policy

  CanniMed Therapeutics Receives Municipal Approval from Carp Lake Township to Apply for State of Michigan Licenses for Medical Cannabis Production and Processing

  The Company intends to submit an application for a Class C Grower License as well as a Processor License to the State of Michigan on or about the opening of the application period, December 15, 2017.

  December 14, 2017

   · 

  5 min read
• Genetown

  Verastem Announces Public Offering of Common Stock

  Verastem announced that it intends to offer and sell $25 million of its common stock in an underwritten public offering.

  December 14, 2017

   · 

  3 min read
• 

  FDA

  Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active Psoriatic Arthritis

  The approval was based on data from the Phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program.

  December 14, 2017

   · 

  18 min read
• Business

  Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee

  As part of the deal, Flexion will make an upfront payment of $2 million to GeneQuine and may incur milestone payments of up to $8.7 million through Phase 2 proof of concept (PoC).

  December 14, 2017

   · 

  6 min read
• Business

  Shire Release: Novel Clinical Study Collaboration Announced Designed to Improve Clinical Care for Hemophilia Patients Through Innovative Personalized Treatment

  Shire, RCSI and Science Foundation Ireland, in collaboration with the Irish Haemophilia Society, today jointly announced the initiation of a novel clinical study called “The Irish Personalised Approach to the Treatment of Haemophilia (iPATH).”

  December 14, 2017

   · 

  4 min read
• Emerald Health Announces No Material Change

  The Company announces that it is not aware of any material, undisclosed corporate developments and has no material change to report at this time.

  December 14, 2017

   · 

  1 min read
• Biotech Bay

  CohBar Announces Approval for Listing on the NASDAQ Capital Market

  CohBar’s common stock is expected to commence trading on the NASDAQ Capital Market at the opening of trading on December 15, 2017 under the ticker symbol CWBR.

  December 14, 2017

   · 

  4 min read